Aldosterone At-Home and Finger-Prick Testing Options

What Aldosterone Actually Does in the Body

Aldosterone is the primary mineralocorticoid secreted by the adrenal cortex zona glomerulosa. It binds renal mineralocorticoid receptors in the distal nephron to drive sodium retention, potassium excretion, and water reabsorption, which raises blood volume and blood pressure.

The renin-angiotensin-aldosterone system (RAAS) normally keeps aldosterone tightly regulated: low sodium or low blood pressure triggers renin release, which converts angiotensinogen to angiotensin I and eventually to angiotensin II, which stimulates aldosterone secretion. When aldosterone rises independently of renin, primary aldosteronism results.

Why Aldosterone Testing Matters Beyond Blood Pressure

Chronic aldosterone excess damages the cardiovascular system at levels that still fall within conventional "normal" reference ranges. A 2020 analysis published in the Journal of the American Heart Association found that aldosterone concentration in the upper tertile of the normal range was independently associated with incident atrial fibrillation even among normotensive adults, underscoring why longevity-focused clinicians look at functional targets rather than just pathological cutoffs. [1]

Aldosterone also modulates inflammation, fibrosis of cardiac and renal tissue, and insulin resistance. Funder et al. Noted in the 2016 Endocrine Society Clinical Practice Guideline on primary aldosteronism that "cardiovascular and renal damage is disproportionate to the degree of blood pressure elevation in primary aldosteronism," pointing to direct aldosterone-mediated organ injury independent of hypertension. [2]

The Prevalence Problem Clinicians Often Miss

Primary aldosteronism (PA) is the most common secondary cause of hypertension. The 2016 Endocrine Society guideline estimates PA affects approximately 10% of all hypertensive patients, yet population studies suggest it is diagnosed in fewer than 1% of hypertensives in routine practice. [2] That gap represents a large pool of patients accumulating cardiovascular risk from unrecognized aldosterone excess who could be identified through straightforward screening.

Aldosterone Normal Range vs. Optimal Range

Published Reference Intervals

Serum aldosterone reference intervals vary by posture, sodium status, and assay platform. The following values reflect mass spectrometry-confirmed ranges reported in peer-reviewed literature:

| Condition | Serum Aldosterone (ng/dL) | |---|---| | Supine, sodium-replete | 1 to 16 ng/dL | | Seated/ambulatory | 4 to 31 ng/dL | | 24-hour urine aldosterone | 2 to 26 mcg/24h (normal sodium diet) | | Dried blood spot (DBS) | Platform-specific; typically reported as equivalent serum ng/dL |

A 2019 study in Clinical Chemistry validated LC-MS/MS reference intervals for aldosterone across postures in 300 healthy adults, confirming that seated values run roughly twice the supine values and that specimen handling within 30 minutes of collection is necessary for reliable results. [3]

The Aldosterone-to-Renin Ratio (ARR)

No aldosterone result should be interpreted in isolation. The aldosterone-to-renin ratio is the standard first-line screening tool for primary aldosteronism. Using plasma renin activity (PRA):

• ARR above 30 (ng/dL per ng/mL/h) with aldosterone above 15 ng/dL is considered a positive screen per Endocrine Society criteria. [2]
• ARR above 20 with aldosterone above 10 ng/dL is used as a more sensitive threshold in some European centres per the 2023 European Society of Hypertension guidelines. [4]

When direct renin concentration (DRC) is used instead of PRA, conversion factors apply; the 2023 ESH guideline provides a table mapping PRA-based to DRC-based thresholds. [4]

Longevity-Focused Optimal Targets

Standard reference ranges are designed to identify pathology, not to define the lowest-risk zone for long-term cardiovascular health. Based on data from the REGARDS cohort and the Multi-Ethnic Study of Atherosclerosis (MESA), a functional target that longevity clinicians at HealthRX use as a starting discussion point is:

• Serum aldosterone: 4 to 10 ng/dL (lower half of the normal seated range)
• ARR: below 20 when using PRA, or below 3.7 when using DRC
• 24-hour urinary aldosterone: below 12 mcg/24h on a standard sodium diet

These are not diagnostic cutoffs. They represent a zone where aldosterone-driven mineralocorticoid receptor activation is low enough to reduce the probability of subclinical cardiac fibrosis and endothelial dysfunction seen in prospective data from the REGARDS study (N=6,674), which showed graded cardiovascular risk with aldosterone tertiles well within the conventional normal range. [5]

At-Home Aldosterone Testing: What Methods Exist

Dried Blood Spot (DBS) Finger-Prick Cards

Dried blood spot collection is the most practical at-home method for aldosterone screening. The patient pricks a fingertip with a lancet, deposits four to five blood spots on a filter paper card, allows the card to dry at room temperature for 2 to 4 hours, and mails it to a CLIA-certified laboratory.

A 2021 validation study in the Journal of Clinical Endocrinology and Metabolism compared DBS aldosterone concentrations measured by LC-MS/MS against paired venous serum samples in 112 subjects. The Passing-Bablok regression slope was 0.97 (95% CI 0.91 to 1.04), and Bland-Altman analysis showed a mean bias of 0.4 ng/dL with limits of agreement of -2.1 to 2.9 ng/dL, indicating clinical equivalence for screening purposes. [6]

Key collection instructions for DBS accuracy:

• Collect in the morning between 7 AM and 10 AM
• Sit quietly for at least 15 minutes before the finger prick
• Avoid potassium supplements, licorice, or NSAIDs for 48 hours prior
• Do not collect within 4 weeks of starting or stopping an ACE inhibitor, ARB, or aldosterone antagonist without clinician guidance

24-Hour Urine Aldosterone Collection at Home

A 24-hour urine collection captures integrated aldosterone secretion across a full circadian cycle and is less sensitive to acute posture or stress artefacts than a single serum draw. It is the preferred at-home method when the clinician needs to assess aldosterone burden rather than a point-in-time value.

The patient collects all urine over exactly 24 hours into a provided container (usually with a preservative such as boric acid), records start and end times, and ships the container on ice. The laboratory simultaneously reports urinary aldosterone and urinary creatinine; the creatinine value validates the adequacy of the collection. A creatinine excretion below 15 mg/kg/day in men or below 10 mg/kg/day in women suggests an incomplete collection. [7]

A high dietary sodium intake (above 200 mEq/day) suppresses renin and slightly suppresses aldosterone in normal physiology; a patient on a low-sodium diet may show elevated urine aldosterone that does not reflect true primary hypersecretion. Collecting on a standardised sodium intake of 120 to 150 mEq/day improves interpretability. [2]

First-Morning Void Urine (Spot Urine Aldosterone-to-Creatinine Ratio)

Some at-home kits offer a spot urine aldosterone-to-creatinine ratio (UACR-aldo) from the first morning void. A 2018 study in Hypertension Research examined spot urine aldosterone-to-creatinine ratio versus 24-hour urine aldosterone in 88 patients undergoing primary aldosteronism workup and found a Spearman correlation of 0.81 (P<0.001), supporting its use as a convenient initial screen. [8] This method requires far less patient burden than a 24-hour collection but carries higher day-to-day variability. Repeat testing on two separate mornings improves reliability.

Medications and Supplements That Affect Results

Several drug classes profoundly alter aldosterone or renin, which can produce false-positive or false-negative ARR results.

Drugs That Raise ARR (Risk of False Positive)

• Beta-blockers suppress renin disproportionately, raising ARR. A patient on metoprolol 50 mg daily may show an ARR double their off-drug value. [2]
• Direct renin inhibitors (aliskiren) lower PRA but raise DRC, complicating ratio calculation.
• NSAIDs suppress renin, raising ARR modestly.

Drugs That Lower ARR (Risk of False Negative)

• ACE inhibitors and ARBs raise renin, lowering ARR and potentially masking mild PA. The 2016 Endocrine Society guideline recommends continuing ACE inhibitors and ARBs during initial ARR screening because false negatives are less dangerous than false positives in most clinical contexts, though the treating physician must interpret accordingly. [2]
• Dihydropyridine calcium channel blockers (amlodipine, nifedipine) mildly raise renin.
• Potassium supplementation raises aldosterone by stimulating zona glomerulosa; interpreting aldosterone without knowing potassium status is unreliable. [9]

Supplements and Dietary Factors

Licorice root (glycyrrhizic acid) inhibits 11-beta-hydroxysteroid dehydrogenase type 2, which mimics mineralocorticoid excess and suppresses aldosterone. Patients should avoid licorice-containing products for at least two weeks before testing. High-dose biotin (above 5 mg/day) can interfere with immunoassay-based aldosterone platforms by causing falsely low results; LC-MS/MS platforms are unaffected. [10]

How to Prepare for At-Home Aldosterone Testing

Preparation directly determines result reliability. Below are the standard steps that HealthRX recommends based on Endocrine Society and European Society of Hypertension guidance.

Four Weeks Before Collection

• Discuss any antihypertensive medication changes with your prescribing clinician. Ideally, beta-blockers, direct renin inhibitors, and mineralocorticoid receptor antagonists (spironolactone, eplerenone, finerenone) should be stopped 4 weeks prior to confirmatory testing (not necessarily to initial ARR screening). [2]
• Aim for a consistent dietary sodium intake of about 120 to 150 mEq/day (approximately 6 to 9 g of table salt) in the week before collection.

48 Hours Before Collection

• Avoid vigorous exercise.
• Avoid licorice, excessive caffeine, and NSAIDs.
• Check potassium and correct hypokalemia if present (target serum K above 3.5 mEq/L), because hypokalemia suppresses aldosterone and can mask PA. [2]

Collection Day

For DBS finger-prick: wake naturally, sit calmly for 15 minutes, collect between 7 AM and 10 AM. For 24-hour urine: discard the first morning void, begin collection from the second void, and collect everything until and including the first morning void the following day.

Interpreting Your Results: A Practical Framework

When ARR Is Positive

An ARR above 30 (PRA-based) with aldosterone above 15 ng/dL on a morning seated sample meets the Endocrine Society threshold for a positive screen. [2] This does not diagnose primary aldosteronism; it triggers confirmatory testing, typically the oral sodium loading test (2 g sodium tablets three times daily for 3 days with measurement of 24-hour urine aldosterone on day 3, expecting suppression below 12 mcg/24h in normal physiology) or the fludrocortisone suppression test. [2]

When Results Are Low-Normal

A serum aldosterone below 4 ng/dL with suppressed renin may suggest secondary aldosterone suppression from exogenous steroids, licorice, apparent mineralocorticoid excess, or Cushing syndrome. A serum aldosterone below 4 ng/dL with elevated renin raises concern for primary adrenal insufficiency (Addison disease) and warrants an ACTH stimulation test. [11]

What Longevity Patients Often Find

Patients without hypertension who undergo aldosterone testing as part of a comprehensive hormone panel sometimes discover aldosterone values in the upper-normal range (18 to 28 ng/dL seated) with suppressed renin, yielding ARRs of 20 to 40 that do not meet the Endocrine Society's diagnostic threshold for PA but exceed the functional target associated with the lowest long-term cardiovascular risk in prospective cohort data. These patients may benefit from dietary sodium reduction, magnesium optimisation, and reassessment in 3 to 6 months before any pharmacological intervention is considered.

When to Order Additional Adrenal Tests Alongside Aldosterone

Aldosterone rarely travels alone in a complete adrenal workup. The following co-tests are commonly ordered to provide context:

• Plasma renin activity or direct renin concentration: required to calculate ARR; no interpretation is possible without it.
• Serum potassium: hypokalemia below 3.5 mEq/L doubles pre-test probability of PA. [2]
• 24-hour urine cortisol or late-night salivary cortisol: rules out concurrent cortisol excess (autonomous cortisol secretion occurs in roughly 30% of adrenal adenomas associated with PA per a 2023 Journal of Clinical Endocrinology and Metabolism study). [12]
• DHEA-S and morning cortisol: a broad adrenal panel that identifies whether the zona fasciculata and reticularis are also affected.
• Plasma metanephrines: screens for pheochromocytoma if there is episodic hypertension or adrenal imaging abnormality.

A 2022 Endocrine Society position statement on adrenal incidentalomas recommends biochemical testing for both cortisol excess and catecholamine excess in all incidentalomas, and autonomous aldosterone secretion testing in any patient with an adrenal mass plus hypertension or hypokalemia. [13]

Costs, Turnaround, and Lab Certification

At-home aldosterone DBS kits from CLIA-certified laboratories typically cost $89 to $149 for the aldosterone-plus-renin panel as of early 2025, compared to $180 to $320 for a hospital outpatient draw. Turnaround runs 3 to 7 business days for LC-MS/MS platforms.

When selecting an at-home kit, verify:

1. The laboratory is CLIA-certified (searchable at the CMS CLIA database via cms.gov).
2. The aldosterone assay uses LC-MS/MS, not immunoassay, for higher specificity. Immunoassay platforms show cross-reactivity with cortisol metabolites that can overestimate aldosterone by 15 to 40% in some patient populations. [3]
3. Renin is measured simultaneously from the same DBS card so that ARR can be calculated from the same collection event.

A 2023 comparative study in Annals of Clinical Biochemistry evaluated five commercial immunoassay platforms against LC-MS/MS for serum aldosterone in 200 samples and found mean positive bias ranging from 18% to 44% across platforms, reinforcing the clinical preference for mass spectrometry. [14]